Safety and effectiveness of switching to Abacavir/Lamivudine plus rilpivirine for maintenance therapy in virologically suppressed HIV-1 individuals in Singapore (SEALS)

Lim, Z C ; Hoo, G S ; Ang, J H ; Teng, C B ; Ang, L W ; Lee, C C ; Leo, Y S ; Law, H L ; Ng, O T ; Wong, C S

AIDS research and therapy, 2021-11, Vol.18 (1), p.80-9, Article 80 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível